Author

Stella Waitere-Wijker

Observed names: S Waitere-Wijker, S. Waitere-Wijker, Waitere-Wijker, S

Institution: Boehringer Ingelheim (Netherlands)

Observed institution: Boehringer Ingelheim (Netherlands)

OpenAlex ID: A5035409138

Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4)

2015 · Roland Buhl, François Maltais, et al. · European Respiratory Journal · 313

Dose-finding study for tiotropium and olodaterol when administered in combination via the Respimat® inhaler in patients with COPD

2012 · René Aalbers, M. Reza Maleki-Yazdi, et al. · European Respiratory Journal · 23

Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat® Inhaler in Patients with Chronic Obstructive Pulmonary Disease

2015 · René Aalbers, M. Reza Maleki-Yazdi, et al. · Advances in Therapy · 17

P256 Safety Of Once-daily Tiotropium And Olodaterol Fixed-dose Combination Via The Respimat In Chronic Obstructive Pulmonary Disease In Two 1-year Studies

2014 · R. Buhl, R. Abrahams, et al. · Thorax · 6

P254 Once-daily Tiotropium And Olodaterol Fixed-dose Combination Via The Respimat(R) Improves Outcomes Versus Mono-components In Copd In Two 1-year Studies

2014 · R. Buhl, E. Derom, et al. · Thorax · 5

Safety of once-daily tiotropium and olodaterol fixed-dose combination via the Respimat in chronic obstructive pulmonary disease in two 1-year studies

2015 · R Buhl, R Abrahams, et al. · Pneumologie · 4

Once-daily tiotropium and olodaterol fixed-dose combination via the Respimat improves outcomes vs mono-components in COPD in two 1-year studies

2015 · R Buhl, E Derom, et al. · Pneumologie · 4

Pooled Safety Analysis of Once-Daily Tiotropium and Olodaterol Fixed-Dose Combination via the Respimat in Patients With Chronic Obstructive Pulmonary Disease: Two 1-Year Studies

2014 · Roland Buhl, Roger Abrahams, et al. · CHEST Journal · 4

Author Correction

2015 · Roland Buhl, François Maltais, et al. · European Respiratory Journal · 3

Once-daily tiotropium and olodaterol fixed-dose combination via the respimat improves outcomes vs mono-components in COPD in two 1-year studies

2014 · Roland Buhl, Eric Derom, et al. · European Respiratory Journal · 2

L’administration une fois par jour d’une association fixe de tiotropium et d’olodatérol par Respimat a amélioré les résultats par rapport aux composants individuels dans les BPCO au cours de deux études d’un an

2014 · R. Buhl, E. Derom, et al. · Revue des Maladies Respiratoires · 1

Once-daily tiotropium and olodaterol fixed-dose combination via the respimat improves outcomes vs mono-components in COPD in two 1-year studies

2015 · Chia, M, Reid, J, et al. · Ghent University Academic Bibliography (Ghent University)

Safety of once-daily tiotropium and olodaterol fixed-dose combination via the respimat in chronic obstructive pulmonary disease in two 1-year studies

2015 · Chia, M, Reid, J, et al. · Ghent University Academic Bibliography (Ghent University)

Works count: 13

Citation count: 382

H-index: 5

I10-index: 3